-
Lopes RD
, Al-Khatib SM, Wallentin L, Yang H, et al.
Efficacy and safety of apixaban compared with warfarin according to patient risk
of stroke and of bleeding in atrial fibrillation: a secondary analysis of a
randomised controlled trial. Lancet 2012.
-
Bangalore S
, Steg G, Deedwania P, Crowley K, et al.
beta-Blocker use and clinical outcomes in stable outpatients with and without
coronary artery disease. JAMA 2012;308:1340-9.
-
Diacon AH
, Dawson R, von Groote-Bidlingmaier F, Symons G, et al.
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and
moxifloxacin combinations: a randomised trial. Lancet 2012;380:986-93.
-
Kaptoge S
, Di Angelantonio E, Pennells L, Wood AM, et al.
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012;367:1310-20.
|